These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 16895579)
1. Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's disease. Mormone E; Matarrese P; Tinari A; Cannella M; Maglione V; Farrace MG; Piacentini M; Frati L; Malorni W; Squitieri F J Neurochem; 2006 Aug; 98(4):1090-9. PubMed ID: 16895579 [TBL] [Abstract][Full Text] [Related]
3. Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients. Almeida S; Sarmento-Ribeiro AB; Januário C; Rego AC; Oliveira CR Biochem Biophys Res Commun; 2008 Oct; 374(4):599-603. PubMed ID: 18625199 [TBL] [Abstract][Full Text] [Related]
4. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Sawa A; Wiegand GW; Cooper J; Margolis RL; Sharp AH; Lawler JF; Greenamyre JT; Snyder SH; Ross CA Nat Med; 1999 Oct; 5(10):1194-8. PubMed ID: 10502825 [TBL] [Abstract][Full Text] [Related]
5. Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models. Browne SE Ann N Y Acad Sci; 2008 Dec; 1147():358-82. PubMed ID: 19076457 [TBL] [Abstract][Full Text] [Related]
6. Time-lapse analysis of aggregate formation in an inducible PC12 cell model of Huntington's disease reveals time-dependent aggregate formation that transiently delays cell death. Gong B; Lim MC; Wanderer J; Wyttenbach A; Morton AJ Brain Res Bull; 2008 Jan; 75(1):146-57. PubMed ID: 18158109 [TBL] [Abstract][Full Text] [Related]
7. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons. Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA haplogroups do not influence the Huntington's disease phenotype. Mancuso M; Kiferle L; Petrozzi L; Nesti C; Rocchi A; Ceravolo R; Orsucci D; Maluccio MR; Bonuccelli U; Filosto M; Siciliano G; Murri L Neurosci Lett; 2008 Oct; 444(1):83-6. PubMed ID: 18706972 [TBL] [Abstract][Full Text] [Related]
9. Huntington's disease: the current state of research with peripheral tissues. Sassone J; Colciago C; Cislaghi G; Silani V; Ciammola A Exp Neurol; 2009 Oct; 219(2):385-97. PubMed ID: 19460373 [TBL] [Abstract][Full Text] [Related]
10. Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Kim EH; Sohn S; Kwon HJ; Kim SU; Kim MJ; Lee SJ; Choi KS Cancer Res; 2007 Jul; 67(13):6314-24. PubMed ID: 17616690 [TBL] [Abstract][Full Text] [Related]
11. Necrotic pathway in human osteosarcoma Saos-2 cell death induced by chloroacetaldehyde. Takahashi K; Sakurai K; Takahashi K; Tanaka H; Fujimoto Y Anticancer Drugs; 2007 Jun; 18(5):543-53. PubMed ID: 17414623 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of some cell death features by real time real space microscopy. Smaili SS; Rosenstock TR; Hsu YT Methods Enzymol; 2008; 442():27-50. PubMed ID: 18662563 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometry-based methods for apoptosis detection in lymphoid cells. Williams O Methods Mol Biol; 2004; 282():31-42. PubMed ID: 15105555 [TBL] [Abstract][Full Text] [Related]
14. Calcium, leukocyte cell death and the use of annexin V: fatal encounters. Trahtemberg U; Atallah M; Krispin A; Verbovetski I; Mevorach D Apoptosis; 2007 Oct; 12(10):1769-80. PubMed ID: 17578666 [TBL] [Abstract][Full Text] [Related]
15. Accelerated expansion of pathogenic mitochondrial DNA heteroplasmies in Huntington's disease. Wang Y; Guo X; Ye K; Orth M; Gu Z Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301881 [TBL] [Abstract][Full Text] [Related]
16. Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients. Chen CM; Wu YR; Cheng ML; Liu JL; Lee YM; Lee PW; Soong BW; Chiu DT Biochem Biophys Res Commun; 2007 Jul; 359(2):335-40. PubMed ID: 17543886 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial alterations related to programmed cell death in tobacco cells under aluminium stress. Panda SK; Yamamoto Y; Kondo H; Matsumoto H C R Biol; 2008 Aug; 331(8):597-610. PubMed ID: 18606389 [TBL] [Abstract][Full Text] [Related]
18. Global changes to the ubiquitin system in Huntington's disease. Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326 [TBL] [Abstract][Full Text] [Related]
19. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats. Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993 [TBL] [Abstract][Full Text] [Related]
20. Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. Formichi P; Radi E; Battisti C; Pasqui A; Pompella G; Lazzerini PE; Laghi-Pasini F; Leonini A; Di Stefano A; Federico A J Cell Physiol; 2007 Sep; 212(3):737-43. PubMed ID: 17458901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]